Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
46
GDRX Quote, Financials, Valuation and Earnings
Last price:
$2.33
Seasonality move
:
-21.45%
Day range:
$2.33 - $2.48
52-week range:
$2.10 - $5.81
Dividend yield:
0%
P/E ratio:
28.75x
P/S ratio:
1.13x
P/B ratio:
1.40x
Volume:
2.5M
Avg. volume:
3M
1-year change:
-49.18%
Market cap:
$838.4M
Revenue:
$792.3M
EPS (TTM):
$0.09
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
GDRX
GoodRx Holdings, Inc.
|
$193.3M | $0.09 | -3.87% | 227.11% | $4.56 |
|
DRIO
DarioHealth Corp.
|
$5M | -$1.59 | -24.79% | -245.23% | $18.00 |
|
MITI
Mitesco, Inc.
|
-- | -- | -- | -- | -- |
|
NRC
National Research Corp.
|
-- | -- | -- | -- | -- |
|
SPOK
Spok Holdings, Inc.
|
$34.6M | $0.24 | 2.09% | 18.18% | $20.00 |
|
VASO
Vaso Corp.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
GDRX
GoodRx Holdings, Inc.
|
$2.47 | $4.56 | $838.4M | 28.75x | $0.00 | 0% | 1.13x |
|
DRIO
DarioHealth Corp.
|
$11.28 | $18.00 | $76.2M | -- | $0.00 | 0% | 6.26x |
|
MITI
Mitesco, Inc.
|
$0.11 | -- | $1.6M | 2.30x | $0.00 | 0% | 24.83x |
|
NRC
National Research Corp.
|
$13.67 | -- | $309.5M | 26.99x | $0.16 | 3.8% | 2.23x |
|
SPOK
Spok Holdings, Inc.
|
$13.56 | $20.00 | $279.3M | 16.94x | $0.31 | 9.22% | 2.01x |
|
VASO
Vaso Corp.
|
$0.18 | -- | $30.8M | 11.90x | $0.00 | 0% | 0.35x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
GDRX
GoodRx Holdings, Inc.
|
47.58% | 0.610 | 37.77% | 2.62x |
|
DRIO
DarioHealth Corp.
|
29.69% | 1.483 | 75.99% | 3.72x |
|
MITI
Mitesco, Inc.
|
-156.54% | 2.778 | 275.98% | 0.00x |
|
NRC
National Research Corp.
|
84.96% | 2.268 | 19.45% | 0.42x |
|
SPOK
Spok Holdings, Inc.
|
4.71% | 0.991 | 2.07% | 0.97x |
|
VASO
Vaso Corp.
|
6.71% | -0.950 | 9.7% | 1.77x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
GDRX
GoodRx Holdings, Inc.
|
$161.2M | $26.4M | 2.63% | 4.78% | 13.48% | $58M |
|
DRIO
DarioHealth Corp.
|
$3M | -$9.5M | -28.66% | -41.55% | -189.42% | -$7.4M |
|
MITI
Mitesco, Inc.
|
-$23.9K | -$1M | -- | -- | -33713.33% | -$120.9K |
|
NRC
National Research Corp.
|
$19.1M | $4.7M | 11.87% | 51.49% | 13.26% | $6.1M |
|
SPOK
Spok Holdings, Inc.
|
$20M | $4.5M | 10.33% | 10.88% | 13.38% | $7.6M |
|
VASO
Vaso Corp.
|
$13.9M | $1.5M | 8.84% | 9.61% | 6.79% | $3M |
GoodRx Holdings, Inc. vs. Competitors
-
Which has Higher Returns GDRX or DRIO?
DarioHealth Corp. has a net margin of 0.57% compared to GoodRx Holdings, Inc.'s net margin of -41.48%. GoodRx Holdings, Inc.'s return on equity of 4.78% beat DarioHealth Corp.'s return on equity of -41.55%.
Company Gross Margin Earnings Per Share Invested Capital GDRXGoodRx Holdings, Inc.82.22% $0.00 $1.1B DRIODarioHealth Corp.60.22% -$3.05 $106.6M -
What do Analysts Say About GDRX or DRIO?
GoodRx Holdings, Inc. has a consensus price target of $4.56, signalling upside risk potential of 84.64%. On the other hand DarioHealth Corp. has an analysts' consensus of $18.00 which suggests that it could grow by 59.65%. Given that GoodRx Holdings, Inc. has higher upside potential than DarioHealth Corp., analysts believe GoodRx Holdings, Inc. is more attractive than DarioHealth Corp..
Company Buy Ratings Hold Ratings Sell Ratings GDRXGoodRx Holdings, Inc.4 6 0 DRIODarioHealth Corp.3 1 0 -
Is GDRX or DRIO More Risky?
GoodRx Holdings, Inc. has a beta of 1.497, which suggesting that the stock is 49.715% more volatile than S&P 500. In comparison DarioHealth Corp. has a beta of 1.161, suggesting its more volatile than the S&P 500 by 16.051%.
-
Which is a Better Dividend Stock GDRX or DRIO?
GoodRx Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DarioHealth Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GoodRx Holdings, Inc. pays -- of its earnings as a dividend. DarioHealth Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GDRX or DRIO?
GoodRx Holdings, Inc. quarterly revenues are $196M, which are larger than DarioHealth Corp. quarterly revenues of $5M. GoodRx Holdings, Inc.'s net income of $1.1M is higher than DarioHealth Corp.'s net income of -$2.1M. Notably, GoodRx Holdings, Inc.'s price-to-earnings ratio is 28.75x while DarioHealth Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GoodRx Holdings, Inc. is 1.13x versus 6.26x for DarioHealth Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GDRXGoodRx Holdings, Inc.1.13x 28.75x $196M $1.1M DRIODarioHealth Corp.6.26x -- $5M -$2.1M
-
Which has Higher Returns GDRX or MITI?
Mitesco, Inc. has a net margin of 0.57% compared to GoodRx Holdings, Inc.'s net margin of -106766.67%. GoodRx Holdings, Inc.'s return on equity of 4.78% beat Mitesco, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital GDRXGoodRx Holdings, Inc.82.22% $0.00 $1.1B MITIMitesco, Inc.-796.67% -$0.27 -$9.3M -
What do Analysts Say About GDRX or MITI?
GoodRx Holdings, Inc. has a consensus price target of $4.56, signalling upside risk potential of 84.64%. On the other hand Mitesco, Inc. has an analysts' consensus of -- which suggests that it could grow by 305.16%. Given that Mitesco, Inc. has higher upside potential than GoodRx Holdings, Inc., analysts believe Mitesco, Inc. is more attractive than GoodRx Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings GDRXGoodRx Holdings, Inc.4 6 0 MITIMitesco, Inc.0 0 0 -
Is GDRX or MITI More Risky?
GoodRx Holdings, Inc. has a beta of 1.497, which suggesting that the stock is 49.715% more volatile than S&P 500. In comparison Mitesco, Inc. has a beta of 5.563, suggesting its more volatile than the S&P 500 by 456.284%.
-
Which is a Better Dividend Stock GDRX or MITI?
GoodRx Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Mitesco, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GoodRx Holdings, Inc. pays -- of its earnings as a dividend. Mitesco, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GDRX or MITI?
GoodRx Holdings, Inc. quarterly revenues are $196M, which are larger than Mitesco, Inc. quarterly revenues of $3K. GoodRx Holdings, Inc.'s net income of $1.1M is higher than Mitesco, Inc.'s net income of -$3.2M. Notably, GoodRx Holdings, Inc.'s price-to-earnings ratio is 28.75x while Mitesco, Inc.'s PE ratio is 2.30x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GoodRx Holdings, Inc. is 1.13x versus 24.83x for Mitesco, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GDRXGoodRx Holdings, Inc.1.13x 28.75x $196M $1.1M MITIMitesco, Inc.24.83x 2.30x $3K -$3.2M
-
Which has Higher Returns GDRX or NRC?
National Research Corp. has a net margin of 0.57% compared to GoodRx Holdings, Inc.'s net margin of 5.11%. GoodRx Holdings, Inc.'s return on equity of 4.78% beat National Research Corp.'s return on equity of 51.49%.
Company Gross Margin Earnings Per Share Invested Capital GDRXGoodRx Holdings, Inc.82.22% $0.00 $1.1B NRCNational Research Corp.54.31% $0.08 $93M -
What do Analysts Say About GDRX or NRC?
GoodRx Holdings, Inc. has a consensus price target of $4.56, signalling upside risk potential of 84.64%. On the other hand National Research Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that GoodRx Holdings, Inc. has higher upside potential than National Research Corp., analysts believe GoodRx Holdings, Inc. is more attractive than National Research Corp..
Company Buy Ratings Hold Ratings Sell Ratings GDRXGoodRx Holdings, Inc.4 6 0 NRCNational Research Corp.0 0 0 -
Is GDRX or NRC More Risky?
GoodRx Holdings, Inc. has a beta of 1.497, which suggesting that the stock is 49.715% more volatile than S&P 500. In comparison National Research Corp. has a beta of 0.490, suggesting its less volatile than the S&P 500 by 50.981%.
-
Which is a Better Dividend Stock GDRX or NRC?
GoodRx Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. National Research Corp. offers a yield of 3.8% to investors and pays a quarterly dividend of $0.16 per share. GoodRx Holdings, Inc. pays -- of its earnings as a dividend. National Research Corp. pays out 100.39% of its earnings as a dividend.
-
Which has Better Financial Ratios GDRX or NRC?
GoodRx Holdings, Inc. quarterly revenues are $196M, which are larger than National Research Corp. quarterly revenues of $35.2M. GoodRx Holdings, Inc.'s net income of $1.1M is lower than National Research Corp.'s net income of $1.8M. Notably, GoodRx Holdings, Inc.'s price-to-earnings ratio is 28.75x while National Research Corp.'s PE ratio is 26.99x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GoodRx Holdings, Inc. is 1.13x versus 2.23x for National Research Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GDRXGoodRx Holdings, Inc.1.13x 28.75x $196M $1.1M NRCNational Research Corp.2.23x 26.99x $35.2M $1.8M
-
Which has Higher Returns GDRX or SPOK?
Spok Holdings, Inc. has a net margin of 0.57% compared to GoodRx Holdings, Inc.'s net margin of 9.46%. GoodRx Holdings, Inc.'s return on equity of 4.78% beat Spok Holdings, Inc.'s return on equity of 10.88%.
Company Gross Margin Earnings Per Share Invested Capital GDRXGoodRx Holdings, Inc.82.22% $0.00 $1.1B SPOKSpok Holdings, Inc.58.95% $0.15 $156.1M -
What do Analysts Say About GDRX or SPOK?
GoodRx Holdings, Inc. has a consensus price target of $4.56, signalling upside risk potential of 84.64%. On the other hand Spok Holdings, Inc. has an analysts' consensus of $20.00 which suggests that it could grow by 54.87%. Given that GoodRx Holdings, Inc. has higher upside potential than Spok Holdings, Inc., analysts believe GoodRx Holdings, Inc. is more attractive than Spok Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings GDRXGoodRx Holdings, Inc.4 6 0 SPOKSpok Holdings, Inc.1 0 0 -
Is GDRX or SPOK More Risky?
GoodRx Holdings, Inc. has a beta of 1.497, which suggesting that the stock is 49.715% more volatile than S&P 500. In comparison Spok Holdings, Inc. has a beta of 0.415, suggesting its less volatile than the S&P 500 by 58.512%.
-
Which is a Better Dividend Stock GDRX or SPOK?
GoodRx Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Spok Holdings, Inc. offers a yield of 9.22% to investors and pays a quarterly dividend of $0.31 per share. GoodRx Holdings, Inc. pays -- of its earnings as a dividend. Spok Holdings, Inc. pays out 171.77% of its earnings as a dividend.
-
Which has Better Financial Ratios GDRX or SPOK?
GoodRx Holdings, Inc. quarterly revenues are $196M, which are larger than Spok Holdings, Inc. quarterly revenues of $33.9M. GoodRx Holdings, Inc.'s net income of $1.1M is lower than Spok Holdings, Inc.'s net income of $3.2M. Notably, GoodRx Holdings, Inc.'s price-to-earnings ratio is 28.75x while Spok Holdings, Inc.'s PE ratio is 16.94x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GoodRx Holdings, Inc. is 1.13x versus 2.01x for Spok Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GDRXGoodRx Holdings, Inc.1.13x 28.75x $196M $1.1M SPOKSpok Holdings, Inc.2.01x 16.94x $33.9M $3.2M
-
Which has Higher Returns GDRX or VASO?
Vaso Corp. has a net margin of 0.57% compared to GoodRx Holdings, Inc.'s net margin of 7.55%. GoodRx Holdings, Inc.'s return on equity of 4.78% beat Vaso Corp.'s return on equity of 9.61%.
Company Gross Margin Earnings Per Share Invested Capital GDRXGoodRx Holdings, Inc.82.22% $0.00 $1.1B VASOVaso Corp.61.33% $0.01 $30.3M -
What do Analysts Say About GDRX or VASO?
GoodRx Holdings, Inc. has a consensus price target of $4.56, signalling upside risk potential of 84.64%. On the other hand Vaso Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that GoodRx Holdings, Inc. has higher upside potential than Vaso Corp., analysts believe GoodRx Holdings, Inc. is more attractive than Vaso Corp..
Company Buy Ratings Hold Ratings Sell Ratings GDRXGoodRx Holdings, Inc.4 6 0 VASOVaso Corp.0 0 0 -
Is GDRX or VASO More Risky?
GoodRx Holdings, Inc. has a beta of 1.497, which suggesting that the stock is 49.715% more volatile than S&P 500. In comparison Vaso Corp. has a beta of 0.466, suggesting its less volatile than the S&P 500 by 53.413%.
-
Which is a Better Dividend Stock GDRX or VASO?
GoodRx Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Vaso Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GoodRx Holdings, Inc. pays -- of its earnings as a dividend. Vaso Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GDRX or VASO?
GoodRx Holdings, Inc. quarterly revenues are $196M, which are larger than Vaso Corp. quarterly revenues of $22.7M. GoodRx Holdings, Inc.'s net income of $1.1M is lower than Vaso Corp.'s net income of $1.7M. Notably, GoodRx Holdings, Inc.'s price-to-earnings ratio is 28.75x while Vaso Corp.'s PE ratio is 11.90x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GoodRx Holdings, Inc. is 1.13x versus 0.35x for Vaso Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GDRXGoodRx Holdings, Inc.1.13x 28.75x $196M $1.1M VASOVaso Corp.0.35x 11.90x $22.7M $1.7M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
77
RNG alert for Feb 23
RingCentral, Inc. [RNG] is down 11.57% over the past day.
Sell
9
FROG alert for Feb 23
JFrog Ltd. [FROG] is down 5.88% over the past day.
Buy
72
SNSE alert for Feb 23
Sensei Biotherapeutics, Inc. [SNSE] is down 3.31% over the past day.
